TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
UNCY

Unicycive Therapeutics Inc

Healthcare · Biotechnology

4.20$ -0.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UNCY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 100.0% 100.0% 98.2% 93.8% 94.4% 97.7% 99.6%
86.2% 78.9% 0.0% 88.4% 16.1% 68.4% 82.6% 59.4%
86.2% 78.9% – 88.4% 16.1% 68.4% 82.6% 84.0%
– – – 1.8% – – – –
4,258.6% 4,752.6% 1,409.3% 12.1% 116.5% 126.8% 76.5% 38.5%
4,258.6% 4,752.6% 1,409.3% 11.2% 116.5% 123.6% 76.2% 38.5%
3,610.3% 2,421.1% 1,232.4% 1.0% 7.1% 2.4% 2.1% 0.4%
206.9% 1,694.7% 90.2% 4.0% 30.0% 5.8% 3.1% 0.6%
-4,158.6% -4,652.6% -1,309.3% 87.9% -16.5% -26.8% 23.5% 61.5%
-5,148.3% -19,252.6% -2,902.9% -85.0% -1,206.4% -454.8% -319.8% -260.2%
5,257.5% 8,024.7% 747.4% 8.0% 53.4% 17.3% 21.2% 32.3%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?